How Much Is Enough? A Surgical Perspective on Imaging Modalities to Estimate Function and Volume of the Future Liver Remnant before Hepatic Resection
Flavio Milana,
Simone Famularo,
Michele Diana,
Kohei Mishima,
Elisa Reitano,
Hwui-Dong Cho,
Ki-Hun Kim,
Jacques Marescaux,
Matteo Donadon,
Guido Torzilli
Affiliations
Flavio Milana
Department of Biomedical Sciences, Humanitas University, Via Montalcini 4, 20090 Pieve Emanuele, MI, Italy
Simone Famularo
Department of Biomedical Sciences, Humanitas University, Via Montalcini 4, 20090 Pieve Emanuele, MI, Italy
Michele Diana
Research Institute Against Digestive Cancer (IRCAD), 67000 Strasbourg, France
Kohei Mishima
Research Institute Against Digestive Cancer (IRCAD), 67000 Strasbourg, France
Elisa Reitano
Research Institute Against Digestive Cancer (IRCAD), 67000 Strasbourg, France
Hwui-Dong Cho
Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea
Ki-Hun Kim
Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea
Jacques Marescaux
Research Institute Against Digestive Cancer (IRCAD), 67000 Strasbourg, France
Matteo Donadon
Department of Health Sciences, Università del Piemonte Orientale, 28100 Novara, NO, Italy
Guido Torzilli
Department of Biomedical Sciences, Humanitas University, Via Montalcini 4, 20090 Pieve Emanuele, MI, Italy
Liver resection is the first curative option for most hepatic primary and secondary malignancies. However, post-hepatectomy liver failure (PHLF) still represents a non-negligible postoperative complication, embodying the most frequent cause of hepatic-related mortality. In the absence of a specific treatment, the most effective way to deal with PHLF is its prevention through a careful preoperative assessment of future liver remnant (FLR) volume and function. Apart from the clinical score and classical criteria to define the safe limit of resectability, new imaging modalities have shown their ability to assist surgeons in planning the best operative strategy with a precise estimation of the FLR amount. New technologies leading to liver and tumor 3D reconstruction may guide the surgeon along the best resection planes combining the least liver parenchymal sacrifice with oncological appropriateness. Integration with imaging modalities, such as hepatobiliary scintigraphy, capable of estimating total and regional liver function, may bring about a decrease in postoperative complications. Magnetic resonance imaging with hepatobiliary contrast seems to be predominant since it simultaneously integrates hepatic function and volume information along with a precise characterization of the target malignancy.